Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Total glucosides of paeony capsules for primary Sjögren's syndrome
ChiCTR2500112499Phase 4Not yet recruiting
- Sponsor
- Jiangsu Provincial Hospital of Traditional Chinese Medicine
- Start
- Nov 2025
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of total glucosides of paeony in Sjögren's syndrome (SS), sponsored by Jiangsu Provincial Hospital of Traditional Chinese Medicine. Primary endpoints: Plasma drug concentration at week12 and Improvement of ESSPRI at week12. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
total glucosides of paeony
03
Conditions
Sjögren's syndrome (SS)
Beyond the preview
Go deeper on ChiCTR2500112499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500112499.